Subjects: IMMUNOLOGICAL adjuvants; COMPLEMENT activation; INULIN
Record details
Subjects: PEMBROLIZUMAB; IMMUNE checkpoint inhibitors; COUGH
Subjects: HOMEOSTASIS; COVID-19; SARS-CoV-2
Subjects: BETA-glucans; CANCER patients; PROGRAMMED death-ligand 1
Subjects: VACCINE effectiveness; CANCER vaccines; IMMUNOLOGICAL adjuvants
Subjects: BICARBONATE ions; IMMUNE response; IMMUNOLOGICAL adjuvants
Subjects: FOLIAR diagnosis; ARTHRITIS prevention; EDEMA prevention
Subjects: THERAPEUTIC use of interferons; MIGRAINE diagnosis; MULTIPLE sclerosis
Subjects: MELANOMA treatment; IMMUNOLOGICAL adjuvants; IMMUNOTHERAPY
Subjects: SPLEEN surgery; IMMUNOGLOBULINS; ANTIPHOSPHOLIPID syndrome
Subjects: IMMUNE checkpoint inhibitors; MELANOMA; METASTASIS
Subjects: LIVER tumors; STAINS & staining (Microscopy); ANIMAL experimentation
Subjects: ROBOTS; RADICAL prostatectomy; PROSTATE cancer
Subjects: CANCER relapse; BIOMARKERS; PANCREATIC cancer
Subjects: IMMUNOLOGICAL adjuvants; BREAST cancer; ENDOCRINE gland cancer
Subjects: POLYMERIC drug delivery systems; DRUG delivery systems; CARBOHYDRATES
Subjects: ULCERATIVE colitis; DRUG approval; DRUG efficacyUNITED States. Food & Drug Administration
Subjects: BIOTHERAPY; VIRAL pneumonia; INTERLEUKINS
Subjects: FLOW cytometry; STAINS & staining (Microscopy); CELL culture
Subjects: AUTOIMMUNE disease diagnosis; CRYOPYRIN-associated periodic syndromes; AUTOIMMUNE diseases
Subjects: REACTIVE oxygen species; IMMUNOMODULATORS; IMMUNOLOGICAL adjuvants
Subjects: THERAPEUTIC use of vitamin C; THERAPEUTIC use of folic acid; THERAPEUTIC use of vitamin EIRAQ
Subjects: RENAL cell carcinoma; DISEASE progression; NEOVASCULARIZATION inhibitors
Subjects: PHENOL analysis; IN vitro studies; DENDRITIC cellsROMANIA
Subjects: ADVERSE health care events -- Risk factors; GLUCOCORTICOIDS -- Therapeutic use; RHEUMATOID arthritis risk factorsMASSACHUSETTS
Subjects: UNSATURATED fatty acids; CYTOKINES; LIPOPROTEINS
Subjects: BLOOD coagulation disorders; SEPSIS; H1N1 influenza
Subjects: THROMBOEMBOLISM risk factors; THROMBOEMBOLISM prevention; VEINS
Subjects: THERAPEUTIC use of monoclonal antibodies; EVALUATION of medical care; TIME
Subjects: STATISTICS; THALIDOMIDE; CONFIDENCE intervalsBRAZIL
Subjects: MEDICAL prescriptions; IMMUNE checkpoint inhibitors; MELANOMABERN (Switzerland)
Subjects: HEPATITIS B treatment; VIRAL antigens; HEPATITIS B
Subjects: BLOOD sugar analysis; GLYCOSYLATED hemoglobin; REFERENCE values
Subjects: COVID-19; SARS-CoV-2 Delta variant; SARS-CoV-2
Subjects: IMMUNOLOGICAL adjuvants; CELL permeability; THERAPEUTICS
Subjects: INFLAMMATION prevention; FUNCTIONAL foods; AYURVEDIC medicineINDIA
Subjects: IMMUNOLOGICAL adjuvants; CANCER vaccines; CARCINOMA in situ
Subjects: MALARIA; PARASITIC diseases; LIPOSOMES
Subjects: TARGETED drug delivery; BONE marrow; DENDRITIC cells
Subjects: GLUCOCORTICOIDS; COVID-19; ACQUISITION of data methodologyMARYLAND
Subjects: MULTIPLE sclerosis; DRUG approval; PRACTICAL politicsUNITED Kingdom
Subjects: POLYSACCHARIDES; MEDICINAL plants; BIOLOGICAL products
Subjects: IMMUNE checkpoint inhibitors; ONCOLOGIC surgery; IMMUNOLOGICAL adjuvants
Subjects: POLYSACCHARIDES; CYTOKINES; STATISTICS
Subjects: STEREOTACTIC radiotherapy; IMMUNOLOGICAL adjuvants; IMMUNOMODULATORS
Subjects: TOLL-like receptors; PATTERN perception receptors; TYPE I interferons
Subjects: THERAPEUTIC use of antimetabolites; BIOTHERAPY; NON-communicable diseases
Subjects: BACTERIAL proteins; BIOLOGICAL models; INTERLEUKINS
Subjects: NEUROLOGICAL disorders; STROKE; CROSS-sectional method